William Blair on Pyxis Oncology Inc. (PYXS): 'encouraged' by enrollment pace of dose-expansion study
Tweet Send to a Friend
William Blair analyst Andy T. Hsieh reiterated a Market Perform rating on Pyxis Oncology Inc. (NASDAQ: PYXS)The analyst commented, "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
